Dose-response effect of serum butyrylcholinesterase activity after clinical doses of pancuronium

Eur J Clin Pharmacol. 2008 Nov;64(11):1043-5. doi: 10.1007/s00228-008-0548-9. Epub 2008 Sep 3.

Abstract

Introduction: Low-dose pancuronium is known to affect serum cholinesterase activity (BChE); however, the dose-response effect of clinical doses of pancuronium on BChE has not been investigated.

Methods: Thirteen ASA I-II patients scheduled for elective surgery requiring muscle relaxation were enrolled in this study. All patients had normal BChE before surgery. Incremental doses of pancuronium (10, 20, 50, and 100 microg/kg) were injected in accordance with surgical needs every 45 min. BChE was measured 3 min after injection by an automatic colorimetric method.

Results: BChE decreased significantly in all except one patient in comparison to the baseline (P < 0.05). However all values remained within normal clinical range. A dose of 100 microg/kg yielded significant decrease in comparison to 10 microg/kg but not to other dosages. Linear regression was not significant for the dose-response relationship (P = 0.05).

Conclusion: After clinical incremental doses of pancuronium, BChE remained within clinical range.

MeSH terms

  • Adult
  • Aged
  • Butyrylcholinesterase / blood*
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neuromuscular Nondepolarizing Agents / pharmacology*
  • Pancuronium / pharmacology*

Substances

  • Neuromuscular Nondepolarizing Agents
  • Butyrylcholinesterase
  • Pancuronium